Background: style='font-family:Verdana;'> Plasmodium falciparum style='font-family:;' '=''> style='font-family:Verdana;'> ( style='font-family:Verdana;'>Pf style='font-fa'/> Molecular Investigation of Genetic Signatures of Selection in iPlasmodium falciparum/iActin-Binding Protein Coronin, Cysteine Desulfurase, and Plasmepsin 2 Gene in Mbita Field Isolates, Western Kenya-Houdou DiarraEdward E. MakhuluPeter O. OdhiamboRobinson M. IrekwaJohnson KinyuaJeremy K. HerrenVictor A. Mobegi-中文期刊【掌桥科研】
首页> 中文期刊>遗传学期刊(英文) >Molecular Investigation of Genetic Signatures of Selection in iPlasmodium falciparum/iActin-Binding Protein Coronin, Cysteine Desulfurase, and Plasmepsin 2 Gene in Mbita Field Isolates, Western Kenya

Molecular Investigation of Genetic Signatures of Selection in iPlasmodium falciparum/iActin-Binding Protein Coronin, Cysteine Desulfurase, and Plasmepsin 2 Gene in Mbita Field Isolates, Western Kenya

     

摘要

style="font-family:Verdana;">Background: style="font-family:Verdana;"> Plasmodium falciparum style="font-family:;" "=""> style="font-family:Verdana;"> ( style="font-family:Verdana;">Pf style="font-family:Verdana;">) resistance to antimalarial drugs is a major impediment to malaria control. The style="font-family:Verdana;">Pf style="font-family:Verdana;">. style="font-family:Verdana;">Kelch 13 style="font-family:Verdana;"> ( style="font-family:Verdana;">PfK13 style="font-family:Verdana;">) gene has been largely reported to be associated with artemisinin resistance. However, recent studies have shown artemisinin resistance without style="font-family:Verdana;">Kech13 style="font-family:Verdana;">mutations suggesting the implication of others genes in artemisinin resistance. In this current study, we focused on mutations in style="font-family:Verdana;">Pf. style="font-family:Verdana;">actin-binding protein coronin, style="font-family:Verdana;">Pf. style="font-family:Verdana;">c style="font-family:Verdana;">ysteine style="font-family:Verdana;">desulfurase and style="font-family:Verdana;">Pf style="font-family:Verdana;">.plasmepsin 2 gene, three putative candidates recently were reported to be style="color:red;"> style="font-family:Verdana;">involved in artemisinin, lumefantrine and piperaquine resistance respectively. style="font-family:Verdana;">Method: style="font-family:Verdana;">Archived blood samples previously collected from asymptomatic school children from December 2016 to October 2018 were used in this study. Genomic DNA was extracted using ISOL style="font-family:Verdana;">ATE II Genomic DNA kit. After PCR amplification, amplicons were purified and sequenced by capillary sequencing. Reads were analyzed for the identification of point mutations previously reported to be involved in drug selection. style="font-family:Verdana;">Results: style="font-family:Verdana;"> Mutations R100K, and G50E involved in reduced artemisinin susceptibility were detected in style="font-family:Verdana;">Pfcoronin style="font-family:Verdana;">. From 2016/17 to 2018 the allele 100k increased frequency (11.2%);while 50E was only observed in 2018 time point rea style="font-family:Verdana;">ching 11.1%. Lumefantrine selection marker K65, in codon (K65Q) was observed at 14.2% in style="font-family:Verdana;">Pfcysteine desulfurase style="font-family:Verdana;">, and the mutant’ allele 65Q gradually increased frequency from 28.5% in 2016/17 to 57.1% in 2018. style="font-family:Verdana;">Pf.pl style="font-family:Verdana;">asmepsin style="font-family:Verdana;">2 style="font-family:Verdana;"> was the less polymorphic gene. Several other polymorphism codons and single nucleotide variants were detected. style="font-family:Verdana;">Conclusion: style="font-family:Verdana;"> The findings indicate the presence of mutations associated with reduced artemisinin susceptibility and lumefantrine selection marker. Therefore, the results call for continuous monitoring of molecular makers in Mbita parasites.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号